Literature DB >> 5521333

In vivo studies with Bay b 5097.

S Shadomy.   

Abstract

Mesh：

Substances：

Year:  1970        PMID： 5521333

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  5 in total

Review 1.  New antifungal therapy in ophthalmology.

Authors:  T W Lieberman; I H Leopold
Journal:  Trans Am Ophthalmol Soc       Date:  1973

Review 2.  An overview of topical antifungal therapy in dermatomycoses. A North American perspective.

Authors:  A K Gupta; T R Einarson; R C Summerbell; N H Shear
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

Review 3.  Clotrimazole: a review of its antifungal activity and therapeutic efficacy.

Authors:  P R Sawyer; R N Brogden; R M Pinder; T M Speight
Journal:  Drugs       Date:  1975       Impact factor: 9.546

4.  Chemotherapeutic evaluation of clotrimazole (Bay b 5097, 1 (o-chloro- - -diphenylbenzyl) imidazole).

Authors:  J A Waitz; E L Moss; M J Weinstein
Journal:  Appl Microbiol       Date:  1971-11

5.  Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies.

Authors:  M A Burgess; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.